天蓝色链霉菌代谢物组测定方法优化及其代谢特征

链霉菌能够产生多种抗生素,具有重要的研究与应用价值。代谢物组学能够定性和定量测定胞内外主要低分子量代谢产物。相对于其他组学,代谢物组学在监控胞内代谢状态、指导物种理性改造方面具有独特优势。本文旨在建立一种快速、准确的链霉菌胞内代谢物分析方法。以模式菌株天蓝色链霉菌为研究对象,基于GC-MS分析平台优化了代谢物组学样品制备流程中的细胞淬灭时间、菌体分离方法、代谢物提取及代谢物衍生化条件,并利用该方法对天蓝色链霉菌不同生长时期各代谢途径的相对活性进行了初步分析。采用"低温淬灭(–40℃,4 min)-快速过滤分离-反复冻融(45 s/3 min)-衍生化(40℃,90 min)"的流程能够鉴定出中心代谢途径(糖酵解、戊糖磷酸途径和TCA循环)、氨基酸代谢途径、脂肪酸代谢途径、核酸代谢途径及部分次级代谢途径中的103种主要代谢物。利用该流程测定发现天蓝色链霉菌细胞生长周期中存在显著的代谢时序差异,并且发现氨基酸与脂肪酸代谢在衔接初级代谢与次级代谢生物合成中具有重要作用。本研究建立的测定方法能够有效地用于天蓝色链霉胞内代谢物分析,该方法将有助于深入刻画链霉菌细胞代谢过程,为菌株代谢工程改造增加次级代谢产物产量提供理性指导。     

链霉菌无痕敲除方法研究进展

链霉菌是革兰氏阳性放线菌,能产生大量具有重要价值的天然代谢产物.随着基因测序技术、分子生物学和合成生物学的不断发展,人类对链霉菌家族有了更深的了解,从分子水平对其基因组进行改造的手段也越来越多.通过对链霉菌基因组合理、高效的精简,将提高链霉菌代谢产物的产量和质量,降低底物原料的消耗量.无痕敲除就是开展此项研究工作的重要手段.文章综述了近年来在链霉菌中广泛使用的分子操作方法并重点对链霉菌无痕敲除方法进行了总结.     

微生物次生代谢的分子调控

摘要：微生物次生代谢产物在工业、农业和医药方面具有重要的应用价值,因此其合成调控长期以来倍受关注。近些年的研究表明,次生代谢产物的生物合成往往与产生菌的生理和发育状态紧密相关,其合成过程错综复杂,形成了多水平的调控网络。在目前所知的一万多种天然抗生素中, 约60%以上是链霉菌产生的。因此,本文主要以链霉菌产生的次生代谢产物为主线,以有突出进展的几种抗生素的研究为代表来介绍近年来抗生素生物合成中分子调控的相关进展,并对未来次生代谢合成调控的发展方向提出一点建议。     

放线菌基因组与生物技术

天蓝色链霉菌全基因组序列的公布 ,对目前工业生产生物活性代谢产物菌株的遗传改造 ,构建生产高价值药物的超级菌 ,以及由微生物资源去寻找新的生物活性代谢产物将产生巨大影响。文中就基因组时代如何发展由基因组信息和化合物库预测次生代谢路径、研究功能基因组学时代的放线菌次生代谢调控、基因工程技术在放线菌抗生素生产中的应用以及体外分子定向进化与分子育种等生物技术问题进行文献综述。     

链霉菌次级代谢调控机制进展

链霉菌除具有复杂的形态分化特征外 ,还可以产生多种具有重要应用价值的次级代谢产物 ,这两个过程密切相关。因此 ,链霉菌存在着原核生物中罕见的庞大而复杂的调控网络。链霉菌在遗传水平有三个层次的调控 ,分别是 :途径特异性调控、多效调控和全局调控。阐明这些调控网络将为利用代谢工程手段提高次级代谢产物的产量并对其进行结构改造奠定理论基础 ,还将有助于发现新的有价值的天然产物。     

聚酮类抗生素生物合成基因簇间的关系

<正>放线菌基因组测序显示基因组中平均有超过20个以上的次生代谢生物合成基因簇,但通常放线菌在试验条件下能检测到的产物仅有2-3个,因此这些次生代谢生物合成基因簇引起了研究者的极大关注,期望通过基因组的挖掘来发现新的代谢产物。除虫链霉菌(Streptomyces avermitilis)产生的16元大环内酯化合物阿维菌素及衍生物被广泛用于防治动植物的线虫类和节肢动物类害虫[1-2]。除虫链霉菌的基因组中,除了阿维菌素生物合成基因簇外,还有其它11种聚酮合成酶类(Polyketide synthesase,PKS)抗生素生物合成基因簇[3]。由于聚酮化合物生物合     

链霉菌的全局调控蛋白DasR

链霉菌能够产生多种次级代谢产物,在临床、农牧业、生物技术等领域具有重要应用价值;对链霉菌的调控网络进行深入研究有助于提高次级代谢产物产量并发现新的次级代谢产物.链霉菌中次级代谢产物生物合成按调控通路分为全局调控与途径特异性调控,其中全局调控蛋白可靶向多种通路特异调控基因和生物合成基因,在链霉菌的生命活动中发挥着更为普遍...     

链霉菌细胞色素P450研究进展

链霉菌中存在大量的细胞色素P450,它们在链霉菌次生代谢产物的生物合成和外来化学物质代谢过程中发挥了重要作用.本文综述了链霉菌中发现的细胞色素P450及其功能的研究进展,分析了存在的问题和研究应用前景.     

链霉菌调控因子bldA的作用机制研究进展

链霉菌是一类具有特殊的形态分化和次生代谢的放线菌。bldA编码链霉菌中唯一能有效识别亮氨酸密码子UUA的tRNA~(Leu),是链霉菌次生代谢途径的必需基因,目前对于其全局调控功能已有详细报道。bldA突变或缺失会导致链霉菌不能完成气生菌丝分化和抗生素合成,这种调控主要是在翻译水平上完成。UUA密码子缺少有效的tRNA翻译,导致mRNA翻译受影响。bldA自身也受到其下游靶基因的负反馈调控。此外,bldA还有很多尚不明确的调控机制,回答这些问题能帮助我们更好地理解抗生素合成途径,为构建有应用前景的菌株奠定理论基础。     

链霉菌次生代谢中双因子调控系统的研究进展

链霉菌次生代谢产物的生物合成受到严格和复杂的调控,而双因子调控系统是其中重要的一类调控因子,在链霉菌中广泛存在,且存在作用方式的多样性和作用机制的复杂性。就近些年研究较多的参与链霉菌次生代谢的两类双因子调控系统(真核型和原核型)的研究状况做了综述,重点阐明其作用机制,并对其研究趋势以及在药物代谢工程中的应用前景进行了展望。     

链霉菌中高效生产聚酮化合物的研究方法及进展北大核心CSCD

聚酮化合物是通过聚酮合成途径产生的一大类结构和生物活性多样的次级代谢产物,是链霉菌产生的主要次级代谢产物,具有重要的经济价值。为了在链霉菌中提高聚酮化合物产量,以满足工业生产需求,近年来,代谢工程的方法被广泛应用,例如,过表达合成途径中限速酶或途径特异性激活蛋白、强化前体供应、去除产物反馈抑制、合成基因簇异源表达等。本文将从代谢工程改造实例入手,全面综述链霉菌中聚酮化合物高效生物合成的研究方法及进展,并对利用合成生物学策略智能动态适配各个相关途径,进而提高该类化合物产量的研究思路进行展望。     

Streptomyces genetics: a genomic perspective

Streptomycetes are gram-positive, soil-inhabiting bacteria of the order Actinomycetales. These organisms exhibit an unusual, developmentally complex life cycle and produce many economically important secondary metabolites, such as antibiotics, immunosuppressants, insecticides, and anti-tumor agents. Streptomyces species have been the subject of genetic investigation for over 50 years, with many studies focusing on the developmental cycle and the production of secondary metabolites. This information provides a solid foundation for the application of structural and functional genomics to the actinomycetes. The complete DNA sequence of the model organism, Streptomyces coelicolor M145, has been published recently, with others expected to follow soon. As more genomic sequences become available, the rational genetic manipulation of these organisms to elucidate metabolic and regulatory networks, to increase the production of commercially important compounds, and to create novel secondary metabolites will be greatly facilitated. This review presents the current state of the field of genomics as it is being applied to the actinomycetes.     

Improved method for the isolation of RNA from (standing liquid cultures of) Streptomycetes

Streptomycetes are complex soil bacteria capable of producing aerial reproductive mycelium and secondary metabolites. We observed novel phenomena such as an extended life cycle including flotation and anaerobiosis using standing liquid cultures. This paper describes an improved method for isolating good quality RNA from standing liquid cultures of S. coelicolor via excellent cell lysis.     

Improved PCR-based method for the direct screening of Streptomyces transformants

Streptomycetes are attractive microorganisms because of their high secretion capacity and for the production of secondary metabolites. We report the improvement of a PCR-based method for screening of solid media-grown Streptomyces transformants. By resuspending mycelium into 2.5-10% dimethyl sulfoxide (DMSO), extensive manipulation prior to PCR could be avoided, thus significantly reducing screening time. Results proved to be both reliable and specific.     

Signals and regulators that govern Streptomyces development

Streptomyces coelicolor is the genetically best characterized species of a populous genus belonging to the gram-positive Actinobacteria. Streptomycetes are filamentous soil organisms, well known for the production of a plethora of biologically active secondary metabolic compounds. The Streptomyces developmental life cycle is uniquely complex and involves coordinated multicellular development with both physiological and morphological differentiation of several cell types, culminating in the production of secondary metabolites and dispersal of mature spores. This review presents a current appreciation of the signaling mechanisms used to orchestrate the decision to undergo morphological differentiation, and the regulators and regulatory networks that direct the intriguing development of multigenomic hyphae first to form specialized aerial hyphae and then to convert them into chains of dormant spores. This current view of S.?coelicolor development is destined for rapid evolution as data from '-omics' studies shed light on gene regulatory networks, new genetic screens identify hitherto unknown players, and the resolution of our insights into the underlying cell biological processes steadily improve.     

Exploiting the genetic potential of polyketide producing streptomycetes

Streptomycetes are the most important bacterial producers of bioactive secondary metabolites such as antibiotics or cytostatics. Due to the emerging resistance of pathogenic bacteria to all commonly used antibiotics, new and modified natural compounds are required for the development of novel drugs. In addition to the classical screening for natural compounds, genome driven approaches like combinatorial biosynthesis are permanently gaining relevance for the generation of new structures. This technology utilizes the combination of genes from different biosynthesis pathways resulting in the production of novel or modified metabolites. The basis for this strategy is the access to a significant number of genes and the knowledge about the activity and specificity of the enzymes encoded by them. A joint initiative was started to exploit the biosynthesis gene clusters from streptomycetes. In this publication, an overview of the strategy for the identification and characterization of numerous biosynthesis gene clusters for polyketides displaying interesting functions and particular structural features is given.